This HTML5 document contains 135 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
n10	http://dx.doi.org/10.1002/
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q34561675

rdf:type

wikibase:Item

schema:description

article científic vědecký článek 2013年論文 научни чланак artikull shkencor artículu científicu espublizáu en 2013 videnskabelig artikel (udgivet 2013) artykuł naukowy 2013年论文 bài báo khoa học научна статия mokslinis straipsnis 2013年論文 artigo científico artículo científico publicado en 2013 articol științific 2013年论文 מאמר מדעי naučni članak სამეცნიერო სტატია artigo científico (publicado na 2013) мақолаи илмӣ wetenschappelijk artikel 2013年論文 научни чланак 2013年論文 vedecký článok مقالهٔ علمی teaduslik artikkel 2013年论文 2013年の論文 2013 թուականի Մարտին հրատարակուած գիտական յօդուած 2013年论文 vitenskapelig artikkel наукова стаття, опублікована в березні 2013 tudományos cikk 2013 nî lūn-bûn мақолаи илмӣ bilimsel makale บทความทางวิทยาศาสตร์ artigo científico (publicado na 2013) επιστημονικό άρθρο artikulong pang-agham articolo scientifico 2013년 논문 научная статья scienca artikolo article scientifique (publié 2013) 2013 թվականի մարտին հրատարակված գիտական հոդված 2013年論文 vitskapeleg artikkel wissenschaftlicher Artikel 2013年论文 article scientific scientific article سائنسی مضمون مقالة علمية tieteellinen artikkeli vetenskaplig artikel ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2013年论文

p:P577

wds:Q34561675-0451568D-852A-402A-8C9C-7D4B6AF85A40

wdt:P577

2013-03-01T00:00:00Z

p:P2093

wds:Q34561675-8CA823F6-4BA0-4228-B744-96B3EBBCE738 wds:Q34561675-6ECDB28C-E9F8-4951-A7A7-71FEB125BE21 wds:Q34561675-D81CEB7E-3CA7-4AAC-AE9D-1C98113B1854 wds:Q34561675-EFFB9495-2E93-4DD5-B7FC-4079FA3DA9A0 wds:Q34561675-C87473B3-ADEB-4714-B756-41BED395908B wds:Q34561675-C2CE36D1-E8BB-4B5C-9ED2-53A1531A2389 wds:Q34561675-BDCBCD8D-9C89-4164-BF19-4B938C6D6587 wds:Q34561675-BDE80C8B-2486-48C1-AB28-BD997E1DFEC1 wds:Q34561675-2041D8F1-D626-40CB-8FB3-2A9E9EF7E493 wds:Q34561675-2120ED3E-A171-416D-AA67-001BB874CF12 wds:Q34561675-05E9B784-E437-4E96-BBEE-C560C2F4D682 wds:Q34561675-61FAF390-61C8-44E4-A21F-694837F48D61 wds:Q34561675-6D83B7D7-8D33-4931-BEB8-8CD4D1CE6608 wds:Q34561675-49D3BCE3-12C8-4995-97CF-9093776B15FA wds:Q34561675-3EE420F6-1B4C-4721-B12E-0A2113090A12 wds:Q34561675-2A4C6C8F-0CC2-45D3-9C0F-F8284D0DFB7D wds:Q34561675-95F3FA00-82D9-4792-ADDB-3A48CCC9AB67

wdt:P2093

Carol A Connell Mario H Cardiel Cristiano Zerbini Peter Nash David Gruben Roy Fleischmann Samuel H Zwillich ORAL Scan Investigators Yoshiya Tanaka Edward Keystone Sriram Krishnaswami Gene Wallenstein Yeong-Wook Song Joel Kremer John D Bradley Bradley T Wyman Birgitta Benda

rdfs:label

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study

skos:prefLabel

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study

schema:name

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study

p:P50

wds:Q34561675-77403E2C-17AE-4C47-9046-C04B8EE93FEA wds:Q34561675-4C3812DD-D429-40E4-8516-44BB8B28C96E wds:Q34561675-0BCFD47F-48AE-4B78-BB1A-CBDDD661B300

wdt:P50

wd:Q54145096 wd:Q91720749 wd:Q47262835

p:P1476

wds:Q34561675-C8EBB1A2-5C6B-4928-BD28-64B28F32EB29

wdt:P1476

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study

p:P304

wds:Q34561675-3EAE703A-3E75-4166-833E-060975A1B25F

wdt:P304

559-570

p:P31

wds:Q34561675-8C9CCFFA-C098-460E-9F87-C634354D8B40

wdt:P31

wd:Q13442814

p:P921

wds:Q34561675-B447A469-0696-427E-8893-16A88FD0E2B4 wds:Q34561675-046FF4C0-3280-45F1-B9A6-7E6E02FB1869

wdt:P921

wd:Q187255 wd:Q422232

p:P698

wds:Q34561675-93492F3A-CD4A-46F2-8E00-8EB813AB38E2

wdtn:P698

n11:23348607

wdt:P698

23348607

p:P1433

wds:Q34561675-874B3EEA-0093-4136-BEA0-49B6A435EBD3

wdt:P1433

wd:Q4797636

p:P433

wds:Q34561675-C74D9D21-41C3-499E-AF76-33718FBA1EC8

p:P478

wds:Q34561675-391B8D75-FD57-4880-85FE-E207D64F88B6

wdt:P433

3

wdt:P478

65

p:P356

wds:Q34561675-F3C08023-2C7E-40A6-9DF5-EAA251BB6D34

wdtn:P356

n10:ART.37816

wdt:P356

10.1002/ART.37816